References
Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687–694
Arnold JS, Bartley MH, Tont SA, Jenkins DP (1966) Skeletal changes in aging and disease. Clin Orthop 49:17–38
Boivin G, Baud C (1984) Microradiographic methods for calcified tissues. In: Dickson G (ed) Methods of calcified tissue preparation. Elsevier, Amsterdam, pp 391–411
Meunier PJ, Boivin G (1997) Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. Bone 21:373–377
Boivin G, Meunier P (2002) The degree of mineralization of bone tissue measured by computerized quantitative contact microadiography. Calcif Tissue Int 70:503–511
Reid SA, Boyde A (1987) Changes in the mineral density distribution in human bone with age: image analysis using backscattered electrons in the SEM. J Bone Miner Res 2:13–22
Skedros JG, Bloebaum RD, Bachus KN, Boyce TM (1993) The meaning of gray levels in backscattered electron images of bone. J Biomed Mater Res 27:47–56
Skedros JG, Bloebaum RD, Bachus KN, Boyce TM, Constantz B (1993) Influence of mineral content and composition on gray levels in backscattered electron images of bone. J Biomed Mater Res 27:57–64
Boyde A, Jones S, Aerssens J, Dequeker J (1995) Mineral density quantitation of the human cortical iliac crest by backscattered electron image analysis: variations with age, sex and degree of osteoarthritis. Bone 16:619–627
Roschger P, Plenk H, Klaushofer K, Eschberger J (1995) A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K-alpha-line intensitites. Scanning Microsc 9:75–88
Roschger P, Fratzl P, Eschberger J, Klaushofer K (1998) Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319–326
Bloebaum R, Skedros J, Vajda E, Bachus K, Constantz B (1997) Determining mineral content variations in bone using backscattered electron imaging. Bone 20:485–490
Nuzzo S, Peyrin F, Cloetens P, Bachurel J, Boivin G (2002) Quantification of the degree of mineralization of bone in three dimension using synchrotron radiation microtemography. Med Phys 29:2672–2681
Fratzl P, Groschner M, Vogl G, et al (1992) Mineral crystals in calcified tissues: a comparative study by SAXS. J Bone Miner Res 7:329–334
Fratzl P, Schreiber S, Klaushofer K (1996) Bone mineralization as studied by small-angle x-ray scattering. Connect Tissue Res 34:247–254
Paschalis EP, Betts F, DiCarlo E, Mendelsohn R, Boskey AL (1997) FTIR microspectroscopic analysis of normal human cortical and trabecular bone. Calcif Tissue Int 61:480–486
Camacho N, Rinnerthaler S, Paschalis E, et al (1999) Complementary information on bone ultrastruture from scanning small angle x-ray scattering and Fourier-transform infrared microspectroscopy. Bone 25:287–293
Glimcher M (1997) The nature of the mineral phase in bone. In: Avioli LV, Krane SM (eds) Metabolic bone disease. Academic Press, San Diego, pp 23–50
Boivin G, Meunier P (2002) Effects of bisphosphonates on matrix mineralization. J Musculoskel Neuron Interact 2:538–543
Roschger P, Grabner B, Messmer P, et al (2001) Influence of intermittent PTH treatment on mineral distribution in the human ilium: a pair biopsy study before and after treatment. J Bone Min Res 17 (Suppl 1):S179
Roschger P, Rinnerthaler S, Yates J, et al (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185–191
Nuzzo S, Lafage-Proust M, Martin-Badosa E, et al (2002) Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17:1372–1382
Ott S, Oleksik A, Lu Y, Harper K, Lips P (2002) Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res 17:341–348
Acknowledgements
The authors express their gratitude to Arthur Santora and John Yates (Merck Research Laboratories, Rahway, NJ) for their constant support. The collaboration of Paul Lips (Amsterdam, The Netherlands), Susan Ott (Seattle, WA), Kristine Harper (Eli Lilly and Company, Indianapolis, IN), Isabelle Tupinon-Mathieu (Institut de Recherches Internationales Servier, Courbevoie, France) is acknowledged. The expert technical assistance of Delphine Farlay, Catherine Simi, and Annie Buffet (INSERM Unité 403, Faculté de Médecine R. Laennec, Lyon, France) is also gratefully acknowledged.
Rights and permissions
About this article
Cite this article
Boivin, G., Meunier, P.J. Methodological considerations in measurement of bone mineral content. Osteoporos Int 14 (Suppl 5), 22–28 (2003). https://doi.org/10.1007/s00198-003-1469-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-003-1469-1